Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Brain Neoplasms 7Small Cell Lung Carcinoma 2Lung Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Neoplasm Metastasis 1Motor Activity 1Melanoma 1Gastrointestinal Neoplasms 1Fibrosis 1Cognitive Dysfunction 1Central Nervous System Carcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Bevacizumab 69atezolizumab 54lenvatinib 42durvalumab 42Nivolumab 38pembrolizumab 35tremelimumab 28Magnetic Resonance Spectroscopy 21Specimen Handling 19tislelizumab 18sintilimab 17Ipilimumab 15Sorafenib 14regorafenib 13cabozantinib 13Radiosurgery 13Radiotherapy 12apatinib 11Blood Specimen Collection 11Immunoglobulin G 10camrelizumab 9Immune Checkpoint Inhibitors 9Disulfides 9X-Rays 8Cyclophosphamide 8donafenib 7Oxaliplatin 7Immunotherapy 7Folfox protocol 7Fluorouracil 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Memantine × 1 year × Clear all
NCT06789757 2025-10-07

(HCC)

Inova Health Care Services

Phase 2 Recruiting
19 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06007846 2025-09-30

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

Inova Health Care Services

Phase 2/3 Recruiting
12 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡